Effects of Early Captopril Treatment and Its Removal on Plasma Angiotensin Converting Enzyme (ACE) Activity and Arginine Vasopressin in Hypertensive Rats (SHR) and Normotensive Rats (WKY)

References

• Wu J. N., Berecek K. H. Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril. Hypertension 1993; 22: 139–146
   PubMed Web of Science ®Google Scholar
• Husain M. K., Manger W. M., Rock T. W., Weiss R. J., Frantz A. G. Vasopressin release due to manual restraint in the rat: role of body compression and comparison with other stressful stimuli. Endocrinology 1979; 104(3)641–644
   PubMed Web of Science ®Google Scholar
• Berecek K. H., Work J., Mitchum T. N., Ram S. Effects of chronic peripheral sympathectomy on plasma levels of, and the pressor response to vasopressin J. Hypertension 1985; 3: 225–230
   Web of Science ®Google Scholar
• Cushman D. W., Cheung H. S. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung Biochem. Pharmacol. 1971; 20: 1637–1648
   Web of Science ®Google Scholar
• Giudicelli J. F., Freslon J. L., Glasson S., Richer C. Captopril and hypertension: development in the SHR Clin. Exp. Hypert. 1980; 2: 1083–1096
   PubMed Web of Science ®Google Scholar
• Harrap S. B., Vander-Merwe W. M., Griffin S. A., Macpherson F., Lever A. F. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 1990; 16: 603–614
   PubMed Web of Science ®Google Scholar
• Nyborg N., Mulvany M. J. Lack of effect of antihypertensive treatment with felodipine on cardiovascular structure of young spontaneously hypertensive rats. Cardiovas Res. 1985; 19: 528–536
   PubMed Web of Science ®Google Scholar
• Christensen K. L., Jespersen L. T., Mulvany M. J. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure J. Hypertension 1989; 7: 83–90
   Web of Science ®Google Scholar
• Wu J. N., Edwards D. G., Zhang L., Berecek K. H. Effects of early treatment of spontaneously hypertensive rats with an angiotensin converting enzyme inhibitor on blood pressure, baroreflex function and cardiac hypertrophy. Hypertension Res. 1994; 17: 243–251
   Google Scholar
• Cushman D. W., Wang F. L., Fung W. C., Grover G. J., Harvey C. M., Scalese R. J., Mitch S. L., DeForrest J. M. Comparison in vitro, ex vitro and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE) Br. J. Clin. Pharmacol. 1989; 28: 115S–130S
   Google Scholar
• Cohen M. L., Kurz K. D., Schenck K. W. Tissue angiotensin-coverting enzyme inhibition as an index of the disposition of enalapril (MK-421) and metabolite MK-422 J. Pharmacol. Exp. Ther. 1983; 226 (1): 192–196
   Web of Science ®Google Scholar
• Unger T. H., Ganten D., Lang R. E. Pharmacology of converting enzyme inhibitors: new aspect, Clin Exp. Hypert. 1983; 5(7–8)1333–1354
   Web of Science ®Google Scholar
• Krulewitz A. H., Fanburg B. L. Stimulation of bovine endothelial cell angiotensin I converting enzyme activity by cyclic AMP-relared agents J. Cell Physiol. 1986; 129: 147–150
   Web of Science ®Google Scholar
• Jackson R. M., Narkates A. J., Oparil S. Impaired pulmonary conversion of angiotensin I to angiotensin II in rats exposed to chronic hypoxia J. Appl. Physiol. 1986; 60: 1121–1127
   PubMed Web of Science ®Google Scholar
• Krulewitz A. H., Fanburg B. L. The effect of oxygen tension on the in vitro production and release of angiotensin converting ensyme by bovine pulmonary artery endothelial cells Am. Rev. Respir. Dis. 1984; 130: 866–869
   PubMed Web of Science ®Google Scholar
• Forslund T., Tikkanen I., Gronhagen-Riska C., Fyhrquist F. Dissociation of the effect of captopril on blood pressure and angiotensin converting enzyme in serum and lungs of spontaneously hypertensive rats. Acta Pharmacol.et Toxicol. 1981; 49: 416–421
   PubMedGoogle Scholar
• Fyhrquist F., Gronhagen-Riska C., Hortling L., Forslund T., Tikkanen I., Klockars M. The induction of angiotensin converting enzyme by its inhibitors Clin. Exp. Hyper. 1983; 5: 1319–1330
   PubMed Web of Science ®Google Scholar
• King S. J., Oparil S., Berecek K. H. Neuronal angiotensin converting enzyme (ACE) gene expression is increased by converting enzyme inhibityors (CEI) Mol. Cell. Neurosci. 1991; 2: 13–20
   PubMedGoogle Scholar
• Schunkert H., Ingelfinger J. R., Hirsch A. T., Pinto Y., Remme W. J., Jacob H., Dzau V. J. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circulation Res. 1993; 72(2)312–318
   PubMed Web of Science ®Google Scholar
• Johnston C. I., Kohzuki M. Angiotensin converting enxyme: localization, regulation and inhibition. Current Advances in ACE inhibitors, D. Sever, G. MacGregor. Churchill Livingstone, London 1989; 3–7
   Google Scholar
• Jackson B., Cubela R., Johnston C. I. Tissue angiotensin converting enzyme (ACE) during changes in the renin-angiotensin system. J. Cardiovasc. Pharmacol. 1987; 10(Suppl 7)S137–S140
   Google Scholar
• Campbell D. J. Circulating and tissue angiotensin systems J. Clin. Invest. 1987; 79: 1–6
   Google Scholar
• Dzau V. J. Vascular renin-angiotensin: a possible autocrine or paracrine system in control of vascular function. J. Cardiovasc. Pharmcol. 1984; 6(Suppl. 2)S377–382
   Google Scholar
• Mizuno K., Nakamura M., Higashimori K., Higashimori K. Local generation and release of angiotensin II in peripheral vascular tissue. Hypertension 1988; 11: 223–229
   PubMed Web of Science ®Google Scholar
• Schomig A., Dietz R., Rascher W., Luth J. B., Mann J. F., Schmidt M., Weber J. Sympathetic vascular tone in spontaneously hypertensive rats J. Klin. Wochenschr. 1978; 56(Suppl 1)131–138
   PubMedGoogle Scholar
• Crofton J. T., Share L., Shade R. E., Allen C., Tarnowski D. Vasopressin in the rat with spontaneous hypertension Am. J. Physiol. 1978; 235(4)H361–H365
   Google Scholar
• Ganten D., Hermann K., Bayer C., Unger T., Lang R. E. Angiotensin synthesis in the brain and increased turnover in hypertensive rats. Science 1983; 221: 869–871
   PubMed Web of Science ®Google Scholar
• Hermann K., Raizada M. K., Sumners C., Phillips M. I. Immunocytochemical and biochemical characterization of angiotensin I and II in cultured neuronal and glial cells from rat brain. Neuroendocrinol. 1988; 47: 125–130
   PubMed Web of Science ®Google Scholar
• Unger T., Ganten D., Lang R. E., Scholkens B. A. Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with two different compounds Hoe 498 and MK421, in spontaneously hypertensive rats J. Cardiovasc. Pharmacol. 1984; 6: 872–880
   PubMed Web of Science ®Google Scholar
• Unger T., Schull B., Rascher W., Lang R. E., Ganten D. Selective activation of the converting enzyme inhibitor MK421 and comparison of its active diacid form with captopril in different tissues of the rat Biochem. Pharmacol. 1982; 31: 3063–3070
   Web of Science ®Google Scholar
• Ganten D., Fuxe K., Phillips M. I., Mann J. F., Ganten U. The brain isorenin-angiotensin system. Biochemistry, localization and possible role in drinking and blood pressure regulation, in Frontiers in Neuroendocrinology, W. F. Ganong, L. Martini. Raven Press, New York 1978; 5: 61–79
   Google Scholar
• Berecek K. H., Wyss J. M., Swords B. H. Alterations in vasopressin mechanisms in captopril treated spontaneously hypertensive rats Clin. Exp. Hypert. 1991; 13(5)1019–1031
   Web of Science ®Google Scholar
• Thibonnier M., Aldigier J. C., Soto M. E., Sassano P., Menard J., Corvol P. Abnormalities and drug-induced alterations of vasopressin in human hypertension. Clin. Sci. 1981; 61(Suppl 7)149S–152S
   PubMed Web of Science ®Google Scholar
• Larochelle P., Genest J., Juchel O., Boucher R., Gutkowska Y., Kekinstry D. Effect of captopril (SQ 14224) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity Can. Med. Asso. J. 1979; 121(3)309–316
   PubMed Web of Science ®Google Scholar
• Ely D. L., Turner M. E. Hypertension in the spontaneously hypertensive rat is linked to the chromosome. Hypertension 1990; 16: 277–281
   PubMed Web of Science ®Google Scholar
• Emerit M. B., Hamon R. M. Trophic effects of neurotransmitters during brain and maturation Biol. Neonate 1992; 62: 193–201
   PubMedGoogle Scholar
• Black J. B., Adler J. E., Dreyfus C. F., Jonakait G. M., Katz D. M., et al. Neurotransmitter plasticity at the molecular level. Science 1984; 225: 1266–1270
   PubMed Web of Science ®Google Scholar
• Lindpaintner K. Blood pressure and heredity. Is it all in the gene or not? Hypertension 1993; 22: 147–149
   Google Scholar
• Crofton J. T., Share L., Shade R. E., Allen C., Tarnowski D. Vasopressin in the rat with spontaneous hypertension Am. J. Physiol. 1978; 135: H361–H365
   Google Scholar
• Mohring J., Kintz J., Schoun J. Studies on the role of vasopressin in blood pressure control of spontaneously hypertensive rats with established hypertension (SHR, stroke prone strain) J. Cardiovasc. Pharmacol. 1979; 1(6)593–608
   PubMed Web of Science ®Google Scholar
• Van Tol H. H.M., van den Buuse M., de Jong W., Burbach J. P.H. Vasopressin and oxytocin gene expression in supraoptic and paraventricular nucleus of the spontaneously hypertensive rate (SHR) during development of hypertension Mol. Brain Res. 1988; 4: 303–311
   Web of Science ®Google Scholar
• Sladek C. D., Devine M. A., Felten S. Y., Aravich P. F., Blair M. L. Abnormalities in hypothalamic and neurohypophysial vasopressin content are not a consequence of hypertension in the spontaneously hypertensive rate. Brain Res. 1988; 445: 39–46
   PubMed Web of Science ®Google Scholar
• Sladek C., Blair M., Sterline C., Mangiapane M. Attenuation of spontaneous hypertension in rats by a vasopressin antagonist. Hypertension 1988; 12: 506–512
   PubMed Web of Science ®Google Scholar
• Cheng S. W.T., Wilson K. M., Mulchahey J. J., Stallworth J. W., Berecek K. H. Vasopressin in neuronal cultures from neonatal rat brain. Hypertension 1989; 13: 902–909
   PubMed Web of Science ®Google Scholar
• Okada H., Suzuki H., Canno Y., Yamamura Y., Saruta T. Chronic and Selective Vasopressin Blockade in Spontaneously Hypertensive Rats. Amer. J. Physiol. 1967; R1467–1471
   Google Scholar
• Owens G. K. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension 1987; 9: 178–187
   PubMed Web of Science ®Google Scholar
• Wolinksky H. Response of the rat aortic media to hypertension: morphological and chemical studies Circ. Res. 1971; 26: 507–522
   Google Scholar
• Weber K. T., Billa C. G. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83: 1849–1865
   PubMed Web of Science ®Google Scholar
• Dostal D. E., Baker K. M. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart: Mediation by AT1 receptor. Am, J. Hypertension 1992; 5: 276–280
   PubMed Web of Science ®Google Scholar
• Gohlke P., Lamberty V., Kuwer I., et al. Vascular remodeling in systemic hypertension. Am. J. Cardiol. 1993; 71: 2E–7E
   PubMed Web of Science ®Google Scholar
• Weber K. T., Billa C. G., Janicki J. S. Myocardial fibrosis: Functional significance and regulator factors Cardiovasc. Res. 1993; 27: 341–348
   Google Scholar